Scientific Plenary III: Cutting Edge Science
Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

https://doi.org/10.1016/j.ygyno.2012.03.034Get rights and content

References (0)

Cited by (0)

View full text
Copyright © 2012 Published by Elsevier Inc.